Together, these results indicate that zinc supplementation may contribute to an increase in Nrf2 expression and SOD synthesis, as well as to an improvement in antioxidant defense, resulting in reduced CVD risk in CKD patients. The gene discussed is NFE2L2; the disease is chronic kidney disease.